Soteria

Soteria

This study is being conducted to assess the long-term safety, tolerability, and efficacy of sotatercept in pulmonary hypertension (PAH) who have participated in and completed a prior PAH sotatercept clinical study.

Please use this link for further information:

Primary Investigator: Peter Engel

Enrolling

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative